• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

估算滞留时间、消除时间、稀释因子和稳态分布容积。

Estimation of permanence time, exit time, dilution factor, and steady-state volume of distribution.

作者信息

Mordenti J, Rescigno A

机构信息

Department of Pharmacokinetics, Genentech Inc., South San Francisco, California 94080.

出版信息

Pharm Res. 1992 Jan;9(1):17-25. doi: 10.1023/a:1018915307554.

DOI:10.1023/a:1018915307554
PMID:1589404
Abstract

General solutions for exist time, permanence time, dilution factor, and volume of distribution at steady state are derived for compartmental and noncompartmental systems. These derivations require that the systems are linear and state-determined. Unique values for these parameters cannot be determined when the site of elimination is not known; in this case the parameters can be defined by a range. Interpretation of this range and its significance and use in clinical situations are illustrated with two examples.

摘要

推导了房室系统和非房室系统中稳态存在时间、持续时间、稀释因子和分布容积的一般解。这些推导要求系统是线性的且状态确定的。当消除部位未知时,无法确定这些参数的唯一值;在这种情况下,参数可以用一个范围来定义。通过两个例子说明了该范围的解释及其在临床情况中的意义和用途。

相似文献

1
Estimation of permanence time, exit time, dilution factor, and steady-state volume of distribution.估算滞留时间、消除时间、稀释因子和稳态分布容积。
Pharm Res. 1992 Jan;9(1):17-25. doi: 10.1023/a:1018915307554.
2
The connection between the steady state (Vss) and terminal (Vbeta) volumes of distribution in linear pharmacokinetics and the general proof that Vbeta >/= Vss.线性药代动力学中稳态分布容积(Vss)与终末分布容积(Vβ)之间的关系以及Vβ≥Vss的一般证明。
J Pharm Sci. 2007 Jun;96(6):1638-52. doi: 10.1002/jps.20804.
3
Steady-state volume of distribution of two-compartment models with simultaneous linear and saturated elimination.具有同时线性和饱和消除的二室模型的稳态分布容积
J Pharmacokinet Pharmacodyn. 2016 Aug;43(4):447-59. doi: 10.1007/s10928-016-9483-z. Epub 2016 Jul 12.
4
On the accuracy of estimation of basic pharmacokinetic parameters by the traditional noncompartmental equations and the prediction of the steady-state volume of distribution in obese patients based upon data derived from normal subjects.传统非房室方程估算基本药代动力学参数的准确性及基于正常受试者数据预测肥胖患者稳态分布容积。
J Pharm Sci. 2011 Jun;100(6):2482-97. doi: 10.1002/jps.22444. Epub 2011 Jan 19.
5
Steady-state volume of distribution and dilution factor.稳态分布容积和稀释因子。
Arzneimittelforschung. 1994 Apr;44(4):571-5.
6
On the volume of distribution at steady state and its relationship with two-compartmental models.关于稳态分布容积及其与二室模型的关系。
J Pharm Sci. 2008 Jan;97(1):111-22. doi: 10.1002/jps.21089.
7
Statistical moments and disposition parameters in a local perfusion system under mammillary nonequilibrium condition.乳头非平衡状态下局部灌注系统中的统计矩和处置参数。
J Pharmacokinet Biopharm. 1990 Oct;18(5):449-58. doi: 10.1007/BF01061704.
8
Mathematical comparison between volume of distribution (V) and volume of distribution at steady-state (Vss) utilizing model-independent approach.使用非模型依赖方法对分布容积(V)和稳态分布容积(Vss)进行数学比较。
Biopharm Drug Dispos. 2004 Mar;25(2):99-101. doi: 10.1002/bdd.372.
9
Compartmental vs. noncompartmental modeling for two accessible pools.针对两个可及池的房室模型与非房室模型
Am J Physiol. 1984 Sep;247(3 Pt 2):R488-96. doi: 10.1152/ajpregu.1984.247.3.R488.
10
Compartmental analysis revisited.再谈房室分析。
Pharmacol Res. 1999 Jun;39(6):471-8. doi: 10.1006/phrs.1999.0467.

引用本文的文献

1
Population pharmacokinetics of serelaxin in patients with acute or chronic heart failure, hepatic or renal impairment, or portal hypertension and in healthy subjects.在急性或慢性心力衰竭、肝或肾功能损害、门静脉高压或健康受试者中,雷洛昔芬的群体药代动力学。
Br J Clin Pharmacol. 2018 Nov;84(11):2572-2585. doi: 10.1111/bcp.13714. Epub 2018 Aug 23.
2
Hematopoietic cells as site of first-pass catabolism after subcutaneous dosing and contributors to systemic clearance of a monoclonal antibody in mice.皮下给药后首过代谢的部位和影响小鼠体内单抗系统清除率的因素:造血细胞。
MAbs. 2018 Jul;10(5):803-813. doi: 10.1080/19420862.2018.1458808. Epub 2018 May 9.
3

本文引用的文献

1
Some considerations on the estimation of steady state apparent volume of distribution and the relationships between volume terms.关于稳态表观分布容积估计及容积术语之间关系的一些思考
J Pharmacokinet Biopharm. 1983 Feb;11(1):93-105. doi: 10.1007/BF01061770.
2
Estimation of average times of residence, recycle and interconversion of blood-borne compounds using tracer methods.使用示踪方法估算血源化合物的平均驻留时间、循环时间和相互转化时间。
J Clin Endocrinol Metab. 1973 Feb;36(2):263-76. doi: 10.1210/jcem-36-2-263.
3
On transfer times in tracer experiments.
Potential errors in the volume of distribution estimation of therapeutic proteins composed of differently cleared components.
不同清除途径组成的治疗性蛋白的分布容积估算中的潜在误差。
J Pharmacokinet Pharmacodyn. 2011 Oct;38(5):581-93. doi: 10.1007/s10928-011-9209-1. Epub 2011 Jul 21.
4
Compartmental analysis and its manifold applications to pharmacokinetics.房室分析及其在药代动力学中的多种应用。
AAPS J. 2010 Mar;12(1):61-72. doi: 10.1208/s12248-009-9160-x. Epub 2009 Nov 25.
5
The pharmacokinetics and absorption of recombinant human relaxin in nonpregnant rabbits and rhesus monkeys after intravenous and intravaginal administration.
Pharm Res. 1993 Feb;10(2):223-7. doi: 10.1023/a:1018982726441.
6
The pharmacokinetics of recombinant human relaxin in nonpregnant women after intravenous, intravaginal, and intracervical administration.重组人松弛素在非妊娠女性静脉内、阴道内和宫颈内给药后的药代动力学。
Pharm Res. 1993 Jun;10(6):834-8. doi: 10.1023/a:1018901009062.
7
Pharmacokinetics and tissue distribution of recombinant human transforming growth factor beta 1 after topical and intravenous administration in male rats.重组人转化生长因子β1在雄性大鼠局部和静脉给药后的药代动力学及组织分布
Pharm Res. 1994 Feb;11(2):213-20. doi: 10.1023/a:1018995005775.
关于示踪剂实验中的转移时间。
J Theor Biol. 1973 Apr;39(1):9-27. doi: 10.1016/0022-5193(73)90202-6.
4
Model-free evaluation and mean-time concept in pharmacokinetics.
Methods Find Exp Clin Pharmacol. 1986 Oct;8(10):593-602.
5
Some clarifications regarding moments of residence times with pharmacokinetic models.关于药代动力学模型中停留时间矩的一些说明。
J Pharmacokinet Biopharm. 1987 Feb;15(1):75-92. doi: 10.1007/BF01062940.
6
Interpretation and estimates of mean residence time with statistical moment theory.
Biopharm Drug Dispos. 1987 May-Jun;8(3):223-34. doi: 10.1002/bdd.2510080304.
7
General treatment of mean residence time, clearance, and volume parameters in linear mammillary models with elimination from any compartment.具有从任何隔室消除的线性乳突模型中平均停留时间、清除率和容积参数的一般处理。
J Pharmacokinet Biopharm. 1988 Oct;16(5):475-92. doi: 10.1007/BF01062381.
8
Mean time parameters dealing with the tissue distribution of drugs: limitations and extensions.处理药物组织分布的平均时间参数:局限性与拓展
J Pharm Sci. 1989 Mar;78(3):264-6. doi: 10.1002/jps.2600780320.
9
Mean time parameters in pharmacokinetics. Definition, computation and clinical implications (Part I).药代动力学中的平均时间参数。定义、计算及临床意义(第一部分)
Clin Pharmacokinet. 1989 Nov;17(5):345-66. doi: 10.2165/00003088-198917050-00004.
10
Designing CD4 immunoadhesins for AIDS therapy.设计用于艾滋病治疗的CD4免疫粘附素。
Nature. 1989 Feb 9;337(6207):525-31. doi: 10.1038/337525a0.